CurrentRheuma
Get Weekly

Topic · page 19 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 721–760 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Semin Arthritis Rheum

    Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria

    Cohort study

  2. Rheumatology (Oxford)

    Single-centre comparison of non-familial, familial and monogenic lupus

    Case-control study

  3. Lupus Sci Med

    Comorbid psoriasis in systemic lupus erythematosus: a cohort study from a tertiary referral centre and the National Patient Register in Sweden

    Cohort study

  4. Lupus Sci Med

    Pregnancy characteristics of patients with systemic lupus erythematosus with different onset times and their risk of adverse pregnancy outcomes: a retrospective cohort study

    Cohort study

  5. Lupus Sci Med

    Deucravacitinib, an oral, selective, allosteric, tyrosine kinase 2 inhibitor, in patients with active SLE: efficacy on patient-reported outcomes in a phase II randomised trial

    Secondary analysis

  6. Lupus

    A retrospective study of long-term outcomes related with initial factors in childhood onset systemic lupus erythematosus

    Cohort study

  7. Lupus

    Maternal and fetal outcomes in pregnant patients with systemic lupus erythematosus: A study from a Latin American developing country

    Cohort study

  8. Arthritis Res Ther

    Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years

    Cohort study

  9. Clin Exp Rheumatol

    Evaluating the metabolic score for insulin resistance in patients with systemic lupus erythematosus

    Cross-sectional study

  10. Rheumatology (Oxford)

    Interferon-γ release assay as an emergent powerful biomarker in systemic lupus erythematosus

    Cohort study

  11. Lupus

    Physician perceptions of challenges and barriers to optimal care of systemic lupus erythematosus in Africa

    Cross-sectional study

  12. Rheumatology (Oxford)

    Association of physicians’ Big Five personality traits with shared decision-making in patients with SLE

    Cross-sectional study

  13. Arthritis Res Ther

    Functional work disability from the perspectives of persons with systemic lupus erythematosus: a qualitative thematic analysis

    Research article

  14. Lupus Sci Med

    Long-term efficacy and safety of the Lupus-Cruces Nephritis protocol: a propensity score study of the Lupus-Cruces and Lupus-Bordeaux cohorts

    Cohort study

  15. Rheumatology (Oxford)

    Bifidobacterium ameliorates lupus nephritis and modulates aberrant differentiation of lymphocyte subsets

    Mechanistic study

  16. Lancet Rheumatol

    ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations

    Guideline or statement

  17. Lupus

    Prevalence, clinical features, and possible associated factors of mesenteric vasculitis occurrence in patients with systemic lupus erythematosus: An age-, year-at SLE diagnosis, and disease duration-controlled study

    Case-control study

  18. Lancet Rheumatol

    Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study

    Case-control study

  19. Rheumatology (Oxford)

    Functional brain networks related to processing speed and memory in SLE: a connectome-based modelling study

    Cross-sectional study

  20. Lupus

    Infection vulnerability in pregnant women with and without systemic lupus erythematosus

    Cohort study

  21. Clin Exp Rheumatol

    The application value of peripheral plasmablasts in the assessment of disease activity and treatment response in systemic lupus erythematosus.

    Cohort study

  22. Lupus

    Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America

    Cohort study

  23. Lupus

    Cardiac magnetic resonance feature tracking evaluates left atrial strain in patients with systemic lupus erythematosus and mitral regurgitation

    Cross-sectional study

  24. Lupus

    Chorea associated with systemic lupus erythematosus- a systematic review

    Meta-analysis

  25. Lupus

    Validity and reliability of the Japanese version of LupusQoL: Assessment of disease-specific health-related quality of life in systemic lupus erythematosus

    Cross-sectional study

  26. Lupus Sci Med

    Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials

    Secondary analysis

  27. Lupus

    Comparison of carotid intima-media thickness and cognitive function in systemic lupus erythematosus patients versus healthy subjects

    Cross-sectional study

  28. Semin Arthritis Rheum

    Strong correlation between SLEDAI and SLE-DAS in the Spanish population: Assessment of discordant patients

    Cohort study

  29. Semin Arthritis Rheum

    Does baseline nephrotic range proteinuria determine the long-term outcomes of membranous lupus nephritis patients??: Nephrotic Range Proteinuria in Membranous Lupus Nephritis

    Cohort study

  30. Lupus Sci Med

    SLE-DAS enables an accurate definition of severe lupus disease activity: derivation and validation in a post hoc study of anifrolumab phase II and III studies

    Secondary analysis

  31. Lupus

    Clinical significance of anti-lipoprotein lipase antibodies in Japanese patients with systemic lupus erythematosus

    Cohort study

  32. Lupus

    Subclinical atherosclerosis is associated with future cardiovascular events in lupus patients at apparent low cardiovascular risk

    Cohort study

  33. Rheumatology (Oxford)

    Effect of rituximab on long-term damage acquisition in patients with systemic lupus erythematosus

    Cohort study

  34. Ann Rheum Dis

    New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity–could anti-LIN28A enhance precision in diagnostics?

    Diagnostic or prognostic study

  35. Semin Arthritis Rheum

    Infectious complications of Belimumab with standard care in systemic lupus erythematosus: a systematic review and meta-analysis

    Meta-analysis

  36. Lupus Sci Med

    Visceral fat, cardiovascular risk factors and quality of life in lupus activity categorised via complement C3

    Cross-sectional study

  37. Rheumatology (Oxford)

    Impact of glucocorticoid tapering speed on renal outcomes in proliferative lupus nephritis: a multicentre retrospective study

    Cohort study

  38. Lupus Sci Med

    Validation of eight endotypes of lupus based on whole-blood RNA profiles

    Diagnostic or prognostic study

  39. Lupus Sci Med

    Efficacy and safety of belimumab versus rituximab for refractory immune thrombocytopenia in patients with connective tissue disease

    Cohort study

  40. Ann Rheum Dis

    Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE

    Cross-sectional study

All 1,848 Briefs in ExploreShowing Briefs 721–760 of 1,848, newest first